β‘ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Axcynsis Therapeutics just got measured.
4/10 means Axcynsis Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
News & MediaClinical TrialsExpanded Access PolicyJoin UsHomeAbout UsPlatform TechnologyPipelineNews & MediaClinical TrialsExpanded Access PolicyJoin Us Antibody-X Conjugate Synthesis HomeAxcynsis2026-06-05T10:41:01+08:00 About Us Axcynsis Therapeutics is a platform-based biotechnology company focusing on the development of Antibody-X Conjugate (AXC) therapies to revolutionise cancer treatments.
Industry: Technology
axcynsis.com1
Structured Data
5
Content Structure
5
Entity Clarity
4
E-E-A-T Signals
5
Technical AEO
3
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Axcynsis Therapeutics.
Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/axcynsis
Cite this score: Engagemii (2026). "AEO Score for Axcynsis Therapeutics." Retrieved from https://engagemii.com/aeo/brands/axcynsis
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform